Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

RFB4(dsFv)-PE38 recombinant immunotoxin × Other hematologic neoplasm × 1 year × Clear all

Sponsor

Interventions

venetoclax 282 Cyclophosphamide 218 Cytarabine 182 Azacitidine 175 fludarabine 154 Specimen Handling 113 fludarabine phosphate 91 Biopsy 87 Rituximab 81 Methotrexate 80 Daunorubicin 73 Vincristine 69 Dexamethasone 66 Whole-Body Irradiation 63 Decitabine 56 Mycophenolic Acid 55 Tacrolimus 53 ibrutinib 52 Etoposide 51 blinatumomab 49 Prednisone 48 obinutuzumab 47 Granulocyte Colony-Stimulating Factor 45 acalabrutinib 44 Melphalan 44 Injections 44 Doxorubicin 42 Stem Cell Transplantation 41 Busulfan 41 Mercaptopurine 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡